Clinical Trial Update: Lignocaine Nebulization for Attenuation of Intubation Stress Response [Phase 4]

View source ↗

Summary

Phase 4 trial update on lignocaine nebulization to attenuate pressor response during intubation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pressor Response

Drugs mentioned

• Lignocaine nebulization (lidocaine)

Snippet

Sponsor: Assiut University | Conditions: Pressor Response | Phase 4 | Status: UNKNOWN